share_log

JMP Securities Maintains Market Outperform on TELA Bio, Lowers Price Target to $15

JMP Securities Maintains Market Outperform on TELA Bio, Lowers Price Target to $15

JMP Securities维持TELA Bio的市场跑赢大盘,将目标股价下调至15美元
Benzinga ·  2023/11/10 14:52

JMP Securities analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target from $20 to $15.

JMP Securities分析师戴维·图尔卡利维持TELA Bio(纳斯达克股票代码:TELA)的股价跑赢大盘,并将目标股价从20美元下调至15美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发